WordNet

used to express refusal or denial or disagreement etc or especially to emphasize a negative statement; "no, you are wrong"
a negative; "his no was loud and clear"
referring to the degree to which a certain quality is present; "he was no heavier than a child" (同)no more
not in any degree or manner; not at all; "he is no better today"
quantifier; used with either mass nouns or plural count nouns for indicating a complete or almost complete lack or zero quantity of; "we have no bananas"; "no eggs left and no money to buy any"; "have you no decency?"; "did it with no help"; "Ill get you there in no time"
a disorder (usually of unknown origin) of the heart muscle (myocardium) (同)myocardiopathy
the fifth of the seven canonical hours; about 3 p.m.

PrepTutorEJDIC

《名詞の前に置いて》『一つも』(『一人も,少しも』)・・・『ない』 / 《補語につけて》『決して・・・でない』 / 《省略文で》・・・なし;・・・お断り / 《話》少ししか(あまり)・・・ない / (肯定の問いに対して)『いいえ』;(否定の問いに対して)はい,ええ / 《not, norの前に挿入して》『いや』,否 / 《形容詞の前に置その形容詞を否定して》…どころではない / 《比較級の前に置いて》ちっとも…でない,…と全く同じ / 《… or no の形で》…であってもなくても / 《驚き・困惑・不信などを表して》とんでもない / 《単数形で》『拒否』,「『いいえ』」という返事 / 《複数形で》反対[投]票
妨害する,じゃまする;(…を)妨害する《+『of』+『名』》

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 肥大型心筋症における内科的治療 medical therapy in hypertrophic cardiomyopathy
2. 肥大型心筋症の自然経過 natural history of hypertrophic cardiomyopathy
3. 特殊な問題の治療を含む肥大型心筋症のマネージメントの概要 overview of hypertrophic cardiomyopathy management including treatment of special problems
4. 肥大型心筋症の臨床症状、診断、および評価 clinical manifestations diagnosis and evaluation of hypertrophic cardiomyopathy
5. 閉塞性肥大型心筋症の種類および病態生理 types and pathophysiology of obstructive hypertrophic cardiomyopathy

Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy.

Derda AA1, Thum S1, Lorenzen JM1, Bavendiek U2, Heineke J2, Keyser B3, Stuhrmann M3, Givens RC4, Kennel PJ4, Schulze PC4, Widder JD2, Bauersachs J2, Thum T5.
International journal of cardiology.Int J Cardiol.2015 Oct 1;196:115-22. doi: 10.1016/j.ijcard.2015.05.185. Epub 2015 Jun 5.
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is caused by mutations in different structural genes and induces pathological hypertrophy with sudden cardiac death as a possible consequence. HCM can be separated into hypertrophic non-obstructive and obstructive cardiomyopathy (HNCM/HOCM) with differen
PMID 26086795

Comparison of Outcomes in Patients With Nonobstructive, Labile-Obstructive, and Chronically Obstructive Hypertrophic Cardiomyopathy.

Pozios I1, Corona-Villalobos C2, Sorensen LL1, Bravo PE2, Canepa M1, Pisanello C1, Pinheiro A1, Dimaano VL1, Luo H1, Dardari Z1, Zhou X1, Kamel I2, Zimmerman SL2, Bluemke DA3, Abraham MR1, Abraham TP4.
The American journal of cardiology.Am J Cardiol.2015 Sep 15;116(6):938-44. doi: 10.1016/j.amjcard.2015.06.018. Epub 2015 Jun 26.
Patients with nonobstructive hypertrophic cardiomyopathy (HC) are considered low risk, generally not requiring aggressive intervention. However, nonobstructive and labile-obstructive HC have been traditionally classified together, and it is unknown if these 2 subgroups have distinct risk profiles. W
PMID 26239580

Sherrid MV1.
Current cardiology reviews.Curr Cardiol Rev.2015 Sep 3. [Epub ahead of print]
HCM is the most common inherited heart condition occurring in 1:500 individuals in the general population. Left ventricular outflow obstruction at rest or after provocation occurs in 2/3 of HCM patients and is a frequent cause of limiting symptoms. Pharmacologic therapy is the first-line treatment f
PMID 26333949

One of Six Patients with Non-Ischemic Heart Disease Exhibit Provoked Coronary Spasms: Non-Ischemic Heart Disease Associated with Ischemia?

, , , , ,
Internal Medicine 54(3), 281-286, 2015
… Objective The majority of cardiologists do not perform spasm provocation tests in patients with non-ischemic heart disease (non-IHD) or non-obstructive coronary artery disease (non-ob-CAD). …
NAID 130004903024

PJ-084 Prevalence and Clinical Significance of Dobutamine-Induced Left Ventricular Outflow Tract Obstruction in Symptomatic Patients with Non-Obstructive Hypertrophic Cardiomyopathy(PJ014,Cardiomyopathy/Hypertrophy (Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)

Kasamaki Yuji,Ohta Masakatsu,Nakai Toshiko,Watanabe Ichiro,Hirayama Atsushi,Ozawa Yukio,Shimura Kazuma,Sezai Akira,Shiono Motomi,Minami Kazutomo,Kofune Tatsuya
Circulation journal : official journal of the Japanese Circulation Society 73(Supplement_I), 567, 2009-03-01
NAID 110007511437

境雄大,小倉雄太,木村大輔,對馬敬夫,福田幾夫
日本呼吸器外科学会雑誌 22(7), 1027-1032, 2008-11-15
症例は68歳,男性.高血圧症で治療中であった.胸部X線写真で左上肺野に異常陰影を指摘され,近医で精査を行い,肺癌(腺癌)と診断された.術前評価T1N0M0,Stage IAであった.胸部X線での心胸郭比は55%で,心電図では不完全右脚ブロックを認めた.全身麻酔下に左開胸を行い,肺門部の剥離を開始すると徐脈,心室性期外収縮が出現し,心停止した.開胸心マッサージとカテコラミン静注で心拍動が再開した.手 …
NAID 110007028974